What anesthesiologists should know about paracetamol (acetaminophen)

Minerva Anestesiologica

Volumn 75, Issue 11, 2009, Pages 644-653

  Mattia, C ^a   Coluzzi, F ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Acetaminophen; Analgesics, opioid; Blood platelets; Cannabinoids; Cyclooxygenase; Drug toxicity; Infusion, intravenous; Liver failure; Pain, postoperative; Serotonin

Indexed keywords

ACETANILIDE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CISAPRIDE; CODEINE; DICLOFENAC; GRANISETRON; IBUPROFEN; ISONIAZID; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; NALOXONE; NALTRINDOLE; NONSTEROID ANTIINFLAMMATORY AGENT; ONDANSETRON; OXYCODONE; PARACETAMOL; PHENACETIN; PHENOBARBITAL; PHENYTOIN; PLACEBO; PROPRANOLOL; RANITIDINE; RIFAMPICIN; ROFECOXIB; SEROTONIN 1A ANTAGONIST; TRAMADOL; TROPISETRON; WARFARIN;

ANALGESIC ACTIVITY; ANESTHESIST; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; BIOEQUIVALENCE; CHRONIC PAIN; CLINICAL TRIAL; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG INHIBITION; DRUG MECHANISM; DRUG METABOLISM; DRUG RECEPTOR BINDING; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER FAILURE; LIVER TOXICITY; LOADING DRUG DOSE; NEPHROTOXICITY; NONHUMAN; OPTIMAL DRUG DOSE; OSTEOARTHRITIS; POSTOPERATIVE PAIN; REVIEW; SINGLE DRUG DOSE; THROMBOCYTE AGGREGATION;

ACETAMINOPHEN; ANALGESIA; ANALGESICS, NON-NARCOTIC; ANESTHESIOLOGY; HUMANS; PAIN, POSTOPERATIVE;

EID: 72449133314     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Morse HN. Ueber eine neue Darstellungsmethode der Acetylamidophenole. Ber Deutscher Chem Ges 1878;11:232-233
2. Von Mering J. Beitrage zur Kenntniss der Antipyretica. Ther Monatsch 1893;7:577-587
3. Bertolini A, Ferrari A, Ottani A, Guerzoni S, Tacchi R, Leone S. Paracetamol: new vistas of an old drug. CNS Drug Reviews 2006;12:250-275 (Pubitemid 46047791)
4. Smith HS Potential analgesic mechanisms of acetaminophen. Pain Physician 2009;12:269-280
5. Graham GG, Scott KF. Mechanism of action of paracetamol. Am J Therapeutics 2005;12:46-55.
6. Raffa RB, Walker EA, Sterious SN. Opioid receptors and acetaminophen (paracetamol). Eur J Pharmacol 2004;503:209-210
7. Roca-Vinardell A, Ortega-Alvaro A, Gilbert-Rahola J, Micò JA. The role of 5HT1A/B autoreceptors in the antinociceptive effect of systemic administration of acetaminophen. Anesthesiology 2003;98:41-47
8. Bujalska M. Effects of nitric oxide synthase inhibition on antinociceptive action of different doses of acetaminophen. Polish J Pharma 2004;56:605-610 (Pubitemid 40123662)
9. Ottani A, Leone S, Sandrini M, Ferrari A, Bertolini A. The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors. Eur J Pharmacol 2006;531:280-281 (Pubitemid 43202247)
10. Flower R, Vane JR. Inhibition of prostaglandine synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol). Nature 1972;240:410-411
11. Chandrasekharan NV, Simmons DL. The cyclooxygenases. Genome Biol 2004;5:241.
12. Lucas R, Warner TD, Vojnovic I, Mitchell JA. Cellular mechanisms of acetaminophen: role of cyclooxygenase. FASEB J 2005;19:635-637 (Pubitemid 40471269)
13. Aronoff DM, Oates JA, Boutaud O. New insights into the mechanism of action of acetaminophen: its clinical pharmacologic chracteristics reflect its inhibition of the two prostaglandin H2 synthases. Clin Pharmacol Ther 2006;79:9-19. (Pubitemid 43069574)
14. Ouellet M, Percival MD. Mechanism of paracetamol inhibition of cyclooxygenase isoforms. Arch Biochem Biophys 2001;387:273-280 (Pubitemid 32980589)
15. Boutaud O, Aronoff DM, Richardson JH, Marnett LJ, Oates JA. Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandine H(2) synthases. Proc Natl Acad Sci USA 2002;99:7130-7135
16. Chandrasekharan NV, Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA 2002;99:13926-13931 (Pubitemid 35215482)
17. Botting R, Ayoub SS. COX-3 and the mechanism of action of paracetamol/acetaminophen. Prostaglandins Leukot Essent Fatty Acids 2005;72:85-87
18. Schwab JM, Schluesener HJ, Laufer S. COX-3: just another COX or the solitary elusive target of paracetamol? Lancet 2003;361:981-982
19. Raffa RB, Stone DJ, Tallarida RJ. Discovery of "self- synergistic" spinal/supraspinal antinociception produced by acetaminophen (paracetamol). J Pharmacol Exp Ther 2000;295:291-294
20. Raffa RB, Codd EE. Lack of binding of acetaminophen to 5-HT receptor or uptake sites (or eleven other binding-uptake assays). Life Sci 1996;59:PL37-PL40.
21. Coluzzi F, Mattia C. Mechanism-based treatment in chronic neuropathic pain: the role of antidepressants. Curr Pharm Des 2005;11:2945-2960 (Pubitemid 41149935)
22. Srikiatkhachorn A, Tarasub N, Govitrapong P. Acetaminophen-induced antinociception via central 5-HT2A receptors. Neurochem Int 1999;34:491-498 (Pubitemid 29243891)
23. Bonnefont J, Alloui A, Chapuy E, Clottes E, Eschalier A. Orally administrated paracetamol does not act locally in the rat formalin test. Anesthesiology 2003;99:976-981
24. Pelissier T, Alloui A, Caussade F, Dubray C, Cloarec A, Lavarenne J et al. 5-HT3 receptors mediate spinal 5-HT antinociception: an antisense approach. J Pharmacol Exp Ther 1996;278:8-14.
25. Libert F, Bonnefont J, Bourinet E, Doucet E, Alloui A, Hamon M et al. Acetaminophen: a central analgesic drug that involves a spinal tropisetron-sensitive, non-5-HT3 receptor-mediated effect. Mol Pharmacol 2004;66:728-734 (Pubitemid 39329273)
26. Högestätt ED, Jönsson BA, Edmund A, Andersson DA, Björk H, Alexander JP et al. Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system. J Biol Chem 2005;280:31405-31412 (Pubitemid 41291881)
27. Zygmunt PM, Chuang H, Movahed P, Julius D, Hogestatt ED. The anandamide transport inhibitor AM404 activates vanilloid receptors. Eur J Pharmacol 2000;396:39-42.
28. Courtney P, Doherty M. Key questions concerning paracetamol and NSAIDs for osteoarthritis. Ann Rheum Dis 2002;61:767-773 (Pubitemid 34899065)
29. American College of Rheumatology Subcommitte on osteoarthritis guideline: recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 2000;43:1905-1915
30. Simon LS, Lipman AG, Jacox AK, Caudill-Slosberg M, Gill LH, Keefe FJ et al. Pain in osteoarthritis, reumatoid arthritis and juvenile chronic arthritis. 2nd ed. Glenview, Illinois: American Pain Society; 2002.
31. Gelotte CK, Auiler JF, Lynch JM, Temple AR, Slattery JT. Disposition of acetaminophen at 4, 6, and 8 g/day for 3 days in healthy young adults. Clin Pharmacol Ther 2007;81:840-848
32. Manyike PT, Kharasch ED, Kalhorn TF, Slattery JT. Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolita formation. Clin Pharmacol Ther 2000;67:275-282
33. Larson AM, Polson J, Fontana RJ, Davern TJ, Lalani E, Hynan LS et al. Acetaminophen-induced acute liver failure: results of a United States multi center, prospective study. Hepatology 2005;42:1364-1372 (Pubitemid 43260039)
34. Myers RP, Shaheen AA, Li B, Dean S, Quan H. Impact of liver disease, alcohol abuse, and unintentional ingestions on the outcomes of acetaminophen overdose. Clin Gastroenterol Hepatol 2008;6:918-925
35. Juhl GI, Norholt SE, Tonneses E, Hiesse-Provost O, Jensen TS. Analgesic efficacy and safety of intravenous paracetamol (acetaminophen) administrated as a 2 g starting dose following third molar surgery. Eur J Pain 2006;10:371-377
36. Silvanto M, Munsterhjelm E, Savolainen S, Tiainen P, Niemi T, Ylikorkala O et al. Effect of 3 g of intravenous paracetamol on post-operative analgesia, platelet function and liver enzymes in patients undergoing tonsillectomy under local anaesthesia. Acta Anaesthesiol Scand 2007;51:1147-1154 (Pubitemid 47389679)
37. Benson GD, Koff RS, Tolman KG. The therapeutic use of acetaminophen in patients with liver disease. Am J Ther 2005;12:133-141 (Pubitemid 40516030)
38. Kuffner EK, Green JL, Bogdan GM, Knox PC, Palmer RB, Heard K et al. The effect of acetaminophen (four grams a day for three consecutive days) on hepatic tests in acoholic patients - a multi center randomized study. BMC Med 2007;5:13. (Pubitemid 46995480)
39. Mazer M, Perrone J. Acetaminophen-induced nephrotoxicity: pathophysiology, clinical manifestations, and management. J Med Toxicol 2008;4:2-6.
40. Koppert W, Frotsch K, Huzurudin N, Boswald W, Griessinger N, Weisbach V et al. The effects of paracetamol and parecoxib on kidney function in elderly patients undergoing orthopedic surgery. Anesth Analg 2006;103:1170-1176 (Pubitemid 44627341)
41. Munsterhjelm E, Munsterhjelm NM, Niemi TT, Ylikorkala O, Neuvonen PJ, Rosenberg PH. Dose-dependent inhibition of platelet function by acetaminophen in healthy volunteers. Anesthesiology 2005;103:712-717 (Pubitemid 41415519)
42. Munsterhjelm E, Niemi TT, Ylikorkala O, Neuvonen PJ, Rosenberg PH. Influence on platelet aggregation of i.v. parecoxib and acetaminophen in healthy volunteers. Br J Anaesth 2006;97:226-231 (Pubitemid 44295710)
43. Galliard-Grigioni KS, Fehr M, Reinhart WH. Influence of combinations of acetylsalicilic acid, acetaminophen, and diclofenac on platelet aggregation. Eur J Pharmacol 2008;595:65-68
44. Mahel I, Bertrand N, Drouet L, Bat Dit Sollier C, Simoneau G, Mazoyer E et al. Interaction between paracetamol and warfarin in patients: a double-blind, placebo-controlled, randomized study. Haematologica 2006;91:1621-1627 (Pubitemid 46032959)
45. Kiang TKL, Ensom MHH, Chang TKH. UDP-glucuronosyltransferases and clinical drug-drug interactions. Pharmacol Ther 2005;106:97-132.
46. Oscier CD, Milner QJ. Peri-operative use of paracetamol. Anaesthesia 2009;64:65-72.
47. Holmer-Petterson P, Owall A, Jakobsson J. Early bioavailability of paracetamol after oral or intravenous administration. Acta Anaesthesiol Scandinavica 2004;48:867-870 (Pubitemid 38993101)
48. Rygnestad T, Zahlsen K, Samdal FA. Absorption of effervescent paracetamol tablets relative to ordinary paracetamol tablets in healthy volunteers. Eur J Clin Pharmacol 2000;56:141-143 (Pubitemid 30341388)
49. Flouvat B, Leneveu A, Fitoussi S, Delhotal-Landes B, Gendron A. Bioequivalence study comparing a new paracetamol solution for injection and propacetamol after single intravenous infusion in healthy subjects. Intern J Clin Pharmacol Ther 2004;42:50-57 (Pubitemid 38100861)
50. Holmer-Petterson P, Jakobsson J, Owall A. Plasma concentrations following repeated rectal or intravenous administration of paracetamol after heart surgery. Acta Anaesthesiol Scandinavica 2006;50:673-677
51. Toms L, McQuay HJ, Derry S, Moore RA. Single dose oral paracetamol (acetaminophen) for postoperative pain in adults. Cochrane Database Syst Rev 2008;CD004602.
52. Romsing J, Moiniche S, Dahl JB. Rectal and parenteral paracetamol, and paracetamol in combination with NSAIDs, for postoperative analgesia. Br J Anesthesia 2002;88:215-226 (Pubitemid 34144999)
53. Duggan ST, Scott LJ. Intravenous paracetamol (acetaminophen). Drugs 2009;69:101-113
54. Flouvat B, Leneveu A, Fitoussi S, Delhotal-Landes B, Gendron A. Bioequivalence study comparing a new paracetamol solution for injection and propacetamol after single intravenous infusion in healthy subjects. Int J Clin Pharmacol Ther 2004;42:50-57 (Pubitemid 38100861)
55. Remy C, Marret E, Bonnet F. Effects of acetaminophen on morphine side-effects and consumption after major surgery: meta-analysis of randomized controller trials. Br J Anesth 2005;94:505-513 (Pubitemid 40500537)
56. Elia N, Lysakowski C, Tramer MR. Does multimodal analgesia with acetaminophen, nonsteroidal antiinflammatory drugs, or selective cyclooxygenase-2 inhibitors and patient-controlled analgesia morphine offer advantages over morphine alone? Anesthesiology 2005;103:1296-1304
57. Cakan T, Inan N, Culhaoglu S, Bakkal K, Basar H. Intravenous paracetamol improbe the quality of postoperative analgesia but dose not decrease narcotic requirements. J Neurosurg Anesthesiol 2008;20:169-173
58. Toms L, Derry S, Moore RA, McQuay HJ. Single dose oral paracetamol (acetaminophen) with codeine for postoperative pain in adults. Cochrane Database Syst Rev 2009;CD001547.
59. Mattia C, Coluzzi F, Sarzi Puttini P, Viganò R. Paracetamol/Tramadol association: the easy solution for mildmoderate pain. Minerva Med 2008;99:369-390
60. Litkowski LJ, Christensen SE, Adamson DN, Van Dyke T, Han SH, Newman KB et al. Analgesic efficacy and tolerability of oxycodone 5 mg / ibuprofen 400 mg compared with those of oxycodone 5 mg / acetanimophen 325 mg and hydrocodone 7.5 mg / acetaminophen 500 mg in patients with moderate to severe postoperative pain: a randomized, double-blind, placebo-controlled, single dose, parallel-group study in a dental pain model. Clin Ther 2005;27:418-429 (Pubitemid 40732649)
61. Korn S, Vassil TC, Kotey PN, Fricke JR. Comparison of rofecoxib and oxycodone plus acetaminophen in the treatment of acute pain: a randomized, double-blind, placebo-controlled study in patients with moderate to severe postoperative pain in the third molar extraction model. Clin Ther 2004;26:769-778 (Pubitemid 38736966)
62. Gammaitoni AR, Galer BS, Bulloch S, Lacouture P, Caruso F, Ma T et al. Randomized, double-blind, placebo-controlled comparison of the analgesic efficacy of oxycodone 10 mg /acetaminophen 325 mg versus controlled-release oxycodone 20 mg in postsurgical pain. J Clin Pharmacol 2003;43:296-304. (Pubitemid 36232659)
63. Gibbs IA, Anderson BJ. Paracetamol (acetaminophen) pharmacodynamics: interpreting the plasma concentration. Arch Dis Child 2008;93:241-247
64. Kumpulainen E, Kokki H, Kalonen T, Heikkinen M, Savolainen J, Laisalmi M. Paracetamol (acetaminophen) penetrates readily into the cerebrospinal fluido f children after intravenous administration. Pediatrics 2007;119:766-771 (Pubitemid 46556676)
65. Varela ML, Howland MA. Single high-dose acetaminophen in children. Ann Pharmacother 2004;38:1935-1941
66. Arana A, Morton NS, Hansen TG. Treatment with paracetamol in infants. Acta Anaesthesiol Scand 2001;45:20-29
67. Gregoire N, Hovsepian L, Gualano V, Evene E, Dufour G, Gendron A. Safety and pharmacokinetics of paracetamol following intravenous administration of 5 g during the first 24 h with a 2-g starting dose. Clin Pharmacol Ther 2007;81:401-405 (Pubitemid 46371218)